Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 5 | Breast Cancer Research

Fig. 5

From: Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer

Fig. 5

Change in lymphocyte density and association with pathological complete response (pCR). Plot depicts the change in median lymphocyte density between paired pre-treatment and post-treatment surgical samples. The primary sort key is taxane sequence and the secondary sort key is change in lymphocyte density. Annotated rug depicts oestrogen receptor (ER), human epidermal growth factor receptor 2 (HER2) status and taxane sequence for samples corresponding to those depicted in the plot above

Back to article page